Today, the FDA identified a Class I Recall, the most serious type of recall: Medtronic expanded its 2018 recall of remote controllers used with either... | By U.S. Food and Drug Administration | Facebook
![Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some](https://www.fda.gov/files/styles/recall_image_small/public/image-2_32.png?itok=38MZjnu2)
Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some
![Novo Nordisk recalls faulty cartridge holders in insulin pens due to potential health risks - YouTube Novo Nordisk recalls faulty cartridge holders in insulin pens due to potential health risks - YouTube](https://i.ytimg.com/vi/PiqC-xE0xAU/sddefault.jpg)